Brian Springthorpe

Person

Leicestershrie, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Triazolo(4,5-D)pyrimidine compounds
- Patent number RE46276
- Issue date Jan 17, 2017
- AstraZeneca UK Limited
- David Hardem
Information Patent Grant
Piperidine derivatives
- Patent number 8,314,127
- Issue date Nov 20, 2012
- Astrazeneca AB
- Talbir Austin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,709,500
- Issue date May 4, 2010
- AstraZeneca AB
- Lilian Alcaraz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives useful as modulators of chemokine receptor a...
- Patent number 7,517,989
- Issue date Apr 14, 2009
- AstraZeneca AB
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,495,013
- Issue date Feb 24, 2009
- AstraZeneca AB
- Moya Caffrey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives useful as modulators of chemokine receptor a...
- Patent number 7,482,363
- Issue date Jan 27, 2009
- AstraZeneca AB
- Hitesh Sanganee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,348,341
- Issue date Mar 25, 2008
- Astrazeneca AB
- Hitesh Sanganee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives useful as modulators of chemokine receptor a...
- Patent number 7,307,090
- Issue date Dec 11, 2007
- Astrazeneca AB
- Richard Evans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,304,077
- Issue date Dec 4, 2007
- Astrazeneca AB
- Hitesh Sanganee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives useful as modulators of chemokine receptor a...
- Patent number 7,265,227
- Issue date Sep 4, 2007
- Astrazeneca AB
- Richard Evans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted triazolopyrimidines for use in platelet aggregation...
- Patent number 7,250,419
- Issue date Jul 31, 2007
- Astrazeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives and their use as modulators of chemokine (es...
- Patent number 7,238,691
- Issue date Jul 3, 2007
- Astrazeneca AB
- Hitesh Sanganee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,238,811
- Issue date Jul 3, 2007
- Astrazeneca AB
- Aaron Rigby
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,179,922
- Issue date Feb 20, 2007
- Astrazeneca AB
- Aaron Rigby
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds
- Patent number 7,034,032
- Issue date Apr 25, 2006
- Astrazeneca AB
- Roger Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds
- Patent number 6,974,868
- Issue date Dec 13, 2005
- Astrazeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical compounds
- Patent number 6,958,350
- Issue date Oct 25, 2005
- Astrazeneca AB
- Stephen Brough
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted piperidine compounds useful as modulators of chemokine...
- Patent number 6,903,085
- Issue date Jun 7, 2005
- AstraZeneca, AB
- Stephen Thom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bipiperidine compounds
- Patent number 6,903,115
- Issue date Jun 7, 2005
- AstraZeneca AB
- Aaron Rigby
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
[1,2,3]-triazolo[4,5-d] pyrimidine...
- Patent number 6,713,483
- Issue date Mar 30, 2004
- Astrazeneca AB
- Simon Guile
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolo(4,5-d)pyrimidine compounds
- Patent number 6,525,060
- Issue date Feb 25, 2003
- AstraZeneca UK Limited
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bipiperidine derivatives as modulators of CCR3 activity and as H1 a...
- Patent number 6,525,070
- Issue date Feb 25, 2003
- AstraZeneca AB
- Aaron Rigby
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolo(4,5-d)pyrimidine compounds
- Patent number 6,369,064
- Issue date Apr 9, 2002
- Astrazeneca AB
- Roger Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolo[4,5-D]pyrimidinyl derivatives and their us...
- Patent number 6,297,232
- Issue date Oct 2, 2001
- Astrazeneca AB
- Roger Victor Bonnert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor an...
- Patent number 6,251,910
- Issue date Jun 26, 2001
- AstraZeneca UK Limited
- Simon Guile
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, com...
- Patent number 6,156,756
- Issue date Dec 5, 2000
- AstraZeneca UK Limited
- David Hardern
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...
- Publication number 20150152111
- Publication date Jun 4, 2015
- AstraZeneca UK Limited
- David Hardern
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...
- Publication number 20140296258
- Publication date Oct 2, 2014
- AstraZeneca UK Limited
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...
- Publication number 20130109702
- Publication date May 2, 2013
- AstraZeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...
- Publication number 20130072503
- Publication date Mar 21, 2013
- AstraZeneca
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PIPERIDINE DERIVATIVES
- Publication number 20130023562
- Publication date Jan 24, 2013
- AstraZeneca AB
- Talbir Austin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds
- Publication number 20120165348
- Publication date Jun 28, 2012
- AstraZeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Trisubstituted triazolopyrimidines for use in platelet aggregation...
- Publication number 20100069408
- Publication date Mar 18, 2010
- AstraZeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidine Derivatives, Their Process for Preparation, Their Use as...
- Publication number 20090197914
- Publication date Aug 6, 2009
- Peter Cage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Rece...
- Publication number 20090118288
- Publication date May 7, 2009
- AstraZeneca AB
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine Derivatives Useful as Modulators of Chemokine Receptor A...
- Publication number 20090069325
- Publication date Mar 12, 2009
- AstraZeneca AB
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine Derivatives, Their Process for Preparation, Their Use as...
- Publication number 20090023733
- Publication date Jan 22, 2009
- Peter Cage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine Derivatives, Their Process for Preparation, Their Use as...
- Publication number 20090012125
- Publication date Jan 8, 2009
- Peter Cage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidines for the Treatment of Chemokine Mediated Diseases
- Publication number 20080275084
- Publication date Nov 6, 2008
- AstraZeneca AB
- Matthew Perry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine Derivatives for the Treatment of Chemokine Mediated Disease
- Publication number 20080262037
- Publication date Oct 23, 2008
- AstraZeneca AB
- Tobias Mochel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Trisubstituted triazolopyrimidines for use in platelet aggregation...
- Publication number 20080214812
- Publication date Sep 4, 2008
- AstraZeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Piperidine Derivatives
- Publication number 20080207688
- Publication date Aug 28, 2008
- AstraZeneca AB
- Talbir Austin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidines for the Treatment of Chemokine Mediated Diseases
- Publication number 20080200505
- Publication date Aug 21, 2008
- AstraZeneca AB
- Matthew Perry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine
- Publication number 20070276141
- Publication date Nov 29, 2007
- Howard Else
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds
- Publication number 20070265282
- Publication date Nov 15, 2007
- AstraZeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chemical compounds
- Publication number 20070179297
- Publication date Aug 2, 2007
- AstraZeneca AB, a Sweden corporation
- Aaron Rigby
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical compound and assay
- Publication number 20070048215
- Publication date Mar 1, 2007
- Brian Springthorpe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical compounds
- Publication number 20070032523
- Publication date Feb 8, 2007
- Moya Caffrey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine derivatives for the treatment of chemokine or h1 mediate...
- Publication number 20060281726
- Publication date Dec 14, 2006
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical compounds
- Publication number 20060264463
- Publication date Nov 23, 2006
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel piperidine derivatives for use in the treatment of chemokine...
- Publication number 20060040984
- Publication date Feb 23, 2006
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds
- Publication number 20060025590
- Publication date Feb 2, 2006
- AstraZeneca AB
- David Hardern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted piperidine compounds useful as modulators of chemokine...
- Publication number 20050250792
- Publication date Nov 10, 2005
- Stephen Thom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine derivatives useful as modulators of chemokine receptor a...
- Publication number 20050182094
- Publication date Aug 18, 2005
- Hitesh Sanganee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidine derivatives useful as modulators of chemokine receptor a...
- Publication number 20050176708
- Publication date Aug 11, 2005
- Christopher Luckhurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical compounds
- Publication number 20050171092
- Publication date Aug 4, 2005
- AstraZeneca AB, a Sweden corporation
- Aaron Rigby
- C07 - ORGANIC CHEMISTRY

Brian Springthorpe

Person

Patents Grantslast 30 patents

Triazolo(4,5-D)pyrimidine compounds

Piperidine derivatives

Chemical compounds

Piperidine derivatives useful as modulators of chemokine receptor a...

Chemical compounds

Piperidine derivatives useful as modulators of chemokine receptor a...

Chemical compounds

Piperidine derivatives useful as modulators of chemokine receptor a...

Chemical compounds

Piperidine derivatives useful as modulators of chemokine receptor a...

Trisubstituted triazolopyrimidines for use in platelet aggregation...

Piperidine derivatives and their use as modulators of chemokine (es...

Chemical compounds

Chemical compounds

Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds

Compounds

Chemical compounds

Substituted piperidine compounds useful as modulators of chemokine...

Bipiperidine compounds

&#x0005B;1,2,3&#x0005D;-triazolo&#x0005B;4,5-d&#x0005D; pyrimidine...

Triazolo(4,5-d)pyrimidine compounds

Bipiperidine derivatives as modulators of CCR3 activity and as H1 a...

Triazolo(4,5-d)pyrimidine compounds

Triazolo&#x0005B;4,5-D&#x0005D;pyrimidinyl derivatives and their us...

1,2,3-triazolo&#x0005B;4,5-d&#x0005D;pyrimidines as P2T receptor an...

Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, com...

Patents Applicationslast 30 patents

TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...

TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...

TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...

TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION...

NOVEL PIPERIDINE DERIVATIVES

Novel compounds

Trisubstituted triazolopyrimidines for use in platelet aggregation...

Piperidine Derivatives, Their Process for Preparation, Their Use as...

N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Rece...

Piperidine Derivatives Useful as Modulators of Chemokine Receptor A...

Piperidine Derivatives, Their Process for Preparation, Their Use as...

Piperidine Derivatives, Their Process for Preparation, Their Use as...

Piperidines for the Treatment of Chemokine Mediated Diseases

Piperidine Derivatives for the Treatment of Chemokine Mediated Disease

Trisubstituted triazolopyrimidines for use in platelet aggregation...

Novel Piperidine Derivatives

Piperidines for the Treatment of Chemokine Mediated Diseases

Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine

Novel compounds

Chemical compounds

Chemical compound and assay

Chemical compounds

Piperidine derivatives for the treatment of chemokine or h1 mediate...

Chemical compounds

Novel piperidine derivatives for use in the treatment of chemokine...

Novel compounds

Substituted piperidine compounds useful as modulators of chemokine...

Piperidine derivatives useful as modulators of chemokine receptor a...

Piperidine derivatives useful as modulators of chemokine receptor a...

Chemical compounds

[1,2,3]-triazolo[4,5-d] pyrimidine...

Triazolo[4,5-D]pyrimidinyl derivatives and their us...

1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor an...